Table 1. Patient characteristics and treatment.

SBRT - stereotactic body radiotherapy; AUA - American Urologic Association

	Percent of Patients
	(n=122)
Age (years): Median 77 (55–88)
60–69	6.40%
70–79	40%
>80	53%
Race
White	52%
Black	32%
Other	16%
Prostate Volume (cc)	Median 41.1 (7 - 160)
Body Mass Index (kg/m²)
<18.5	1%
18.5–24.9	23%
25.0–29.9	48%
30.0–34.9	20%
35.0–39.9	4%
40.0–44.9	3%
Charlson Comorbidity Index
0	48%
1	25%
2	16%
3	11%
Risk Group (D’Amico)
Low	7%
Intermediate	52%
High	40%
Hormone Therapy
3 months	77%
4 months	8%
6 months	15%
SBRT Dose
35	34%
36.25	66%
AUA Baseline
0–7 (Mild)	39%
8–19 (Moderate)	45%
≥20 (Severe)	16%